- Report
- May 2026
- 373 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 455 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 278 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 391 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 182 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 762 Pages
Global
From €5091EUR$5,800USD£4,403GBP
- Report
- May 2026
- 274 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 182 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- February 2026
- 250 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- May 2026
- 185 Pages
Global
From €3950EUR$4,500USD£3,416GBP
- Report
- January 2026
- 182 Pages
Global
From €3950EUR$4,500USD£3,416GBP
- Report
- August 2025
- 188 Pages
Global
From €3950EUR$4,500USD£3,416GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,757GBP
- Report
- September 2025
- 148 Pages
Global
From €3510EUR$3,999USD£3,036GBP
- Report
- September 2025
- 149 Pages
Global
From €3510EUR$3,999USD£3,036GBP
- Report
- June 2025
- 135 Pages
Global
From €3510EUR$3,999USD£3,036GBP
- Report
- February 2026
- 134 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- March 2026
- 194 Pages
Global
From €4384EUR$4,995USD£3,792GBP
- Report
- January 2026
- 149 Pages
Global
From €3467EUR$3,950USD£2,999GBP
- Report
- January 2026
- 200 Pages
Global
From €4384EUR$4,995USD£3,792GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more